Active07636591Private limited companyLondon

NANOGENICS LIMITED

Significant control: Thalia Therapeutics PLC (50–75%)

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Nanogenics Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Nanogenics Limited sell?

Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy

Summary

Generated from filed data · no estimates

NANOGENICS LIMITED is an active private limited company (company number 07636591) incorporated on 17 May 2011, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Accounts are on file at Companies House (micro entity) but not yet parsed into this record.

There are 603 companies in research and experimental development on biotechnology in London with filed accounts; the median reports net assets of £440 and is 6 years old.

Ownership and control

1 active · 3 other

Thalia Therapeutics Plc
corporate entity, United Kingdom · since 5 October 2023
- owns 50–75% of shares
- holds 50–75% of voting rights
50–75%
PS
Prof Stephen Lewis Hart
Individual · since 6 April 2016 · ceased 11 May 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
Applisci Ltd
corporate entity, England · since 30 June 2016 · ceased 11 May 2018
- owns 25–50% of shares
- holds 25–50% of voting rights
25–50%
Ryboquin Company Ltd
corporate entity, Scotland · since 11 May 2018 · ceased 5 October 2023
- owns 50–75% of shares
- holds 50–75% of voting rights
- can appoint or remove directors
50–75%

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

Key dates

Incorporated: 17 May 201115 yrs ago
First accounts due: 17 February 20134997 days overdue
Confirmation statement due: 31 May 2027in 219 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

Activity

SIC 72110: Research and experimental development on biotechnology
Accounts type: Micro Entity

Financials

No accounts on record

Accounts exist on the register but their figures are not in this dataset yet.

Filing and accounts signals

Facts from the register · no rating

Incorporated five or more years agoIncorporated 17 May 2011
Accounts past their due dateDue 17 February 2013

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

Timeline

Newest first

31 May 2027Confirmation statement duein 219 days
17 Feb 2013First accounts due4997 days overdue
17 May 2011Incorporated

Similar companies in London

Same activity (research and experimental development on biotechnology), closest in incorporation date

All companies incorporated on 17 May 2011 · in May 2011.

Reminders for NANOGENICS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.